Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model
- 2 July 2019
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 45 (9) , 1506-1514
Abstract
Epigallocatechin-3-gallate (EGCG), derived from green tea, is an active phytochemical against many types of cancer, cardiovascular, neurological and inflammatory diseases. However, its pharmaceutical activity is limited due to low bioavailability and chemical instability. To overcome these limitations, we fabricated spherical, EGCG loaded solid lipid nanoparticles (SLN-EGCG) as an oral delivery system. The SLN-EGCG showed a hydrodynamic diameter of 300.2 ± 3.8 nm with the drug encapsulation efficiency of 81 ± 1.4%. Additionally, a slow and sustained release of EGCG was noted. Mathematical modelling of release kinetic data suggested that the SLN-EGCG followed the Higuchi model and released EGCG via fickian diffusion method. The data on pharmacokinetic parameters indicated significantly improved bioavailability and protection of EGCG from degradation due to encapsulation into SLN. The SLN-EGCG did not show any acute or sub-chronic toxicity when compared with free EGCG in the rat model. Together these data supported the hypothesis that SLN-EGCG is capable of enhancing the bioavailability and stability of EGCG and can be used as an alternative system for oral administration of EGCG.Keywords
Funding Information
- National Tea Research Foundation, Tea Board, Kolkata
This publication has 39 references indexed in Scilit:
- Assessment of plasma concentrations of (−)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverageFood Chemistry, 2011
- Preparation and Characterization of Catalase-Loaded Solid Lipid Nanoparticles Protecting Enzyme against ProteolysisInternational Journal of Molecular Sciences, 2011
- The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer preventionArchives of Biochemistry and Biophysics, 2010
- Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosisDrug Delivery, 2010
- Gelatin nanocarriers as potential vectors for effective management of tuberculosisInternational Journal of Pharmaceutics, 2010
- Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugsJournal of Controlled Release, 2008
- Preparation of Tea Polyphenols-Loaded Solid Lipid Nanoparticles Based on the Phase Behaviors of Hot MicroemulsionsSolid State Phenomena, 2007
- Encapsulation of dexamethasone into biodegradable polymeric nanoparticlesInternational Journal of Pharmaceutics, 2007
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJournal of Controlled Release, 1994